MC

Marc Coucke

Europe, Belgium

Description

Marc Coucke - Founder @ Omega Pharmaceuticals

Investor Profile

Marc Coucke has made 2 investments, with 0 in the past 12 months and 50% as lead.

Stage Focus

  • Post Ipo Equity (50%)
  • Series C (50%)

Country Focus

  • The Netherlands (50%)
  • United States (50%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Artificial Intelligence (Ai)
  • Big Data
  • Bioinformatics
  • Genetics
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Marc Coucke frequently co-invest with?

Waterland Private Equity
Europe, Noord-Holland, The Netherlands, Bussum
Co-Investments: 1
Reference Capital SA
Europe, Geneve, Switzerland, Genève
Co-Investments: 1

What are some of recent deals done by Marc Coucke?

Fagron SA

Rotterdam, Zuid-Holland, The Netherlands

Fagron is a pharmaceutical company specializing in chemicals, equipment, and supplies solutions.

BiotechnologyHealth CareMedicalPharmaceutical
Post Ipo EquityMar 2, 2016
Amount Raised: $239,088,075
SOPHiA GENETICS

Boston, Massachusetts, United States

SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.

Artificial Intelligence (AI)Big DataBioinformaticsBiotechnologyGeneticsHealth CareLife ScienceMedical
Series CDec 16, 2015
Amount Raised: $15,000,000